KYV-101 Clinical Trials
3 recruitingBiologic
Phase 21Phase 31Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Myasthenia GravisGeneralized Myasthenia Gravis
Kyverna Therapeutics66 enrolled15 locationsNCT06193889
Recruiting
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Refractory Lupus NephritisMyasthaenia Gravis
Kyverna Therapeutics70 enrolled1 locationNCT07403188
Recruiting
Phase 1
Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Dermatomyositis
Stanford University21 enrolled2 locationsNCT06298019